Researchers at the Columbia University Medical Center (CUMC) may have found a way to reduce brain damage caused by a stroke or stroke-like event. In a study funded by the National Heart, Lung, and Blood Institute and the National Institute of Neurological Disorders and Stroke, 10-day-old mice that had an hypoxic (lack of oxygen) or ischemic (lack of blood) brain injury were treated with a fat emulsion containing either DHA or EPA—omega-3 fatty acids. The researchers evaluated the mice’s neurological function 24 hours and 8 to 9 weeks after the brain injury. They discovered that the mice treated with the DHA omega-3 fatty acids had a significant reduction in brain injury. This did not hold true for those treated with EPA-omega 3. The DHA group also had significantly better results in multiple brain functions during the 8 and 9 weeks evaluation compared to the EPA-treated mice and the control group which went untreated.Read More
Science Market Update
Since it's founding in 2006, the Herbert and Florence Irving Institute for Clinical and Translational Research at the Columbia University Medical Center, in partnership with the New York-Presbyterian Hospital in New York, has provided more than 2,000 scientists with new opportunities of conducting clinical and translational research leading to quicker developments and deliveries of treatments. Recently, the National Center for Advancing Translational Sciences (NCATS) awarded the Irving Institute a grant of $58.4 million over the next five years to help the Institute further the translational research being conducted.
New York's Columbia University is nearing the completion of an ambitious building project more than three years in the making. Columbia University Medical Center (CUMC) will open its new state-of-the-art building this August. Work began on this 100,000 square-foot, fourteen-story glass tower in September of 2013 thanks in large part due to a financial gift from Dr. Roy Vagelos and his wife Diana. So it seems fitting that the building will be named the Vagelos Education Center.
Tags: Medical Center, Biotech Event, New York, Columbia University, East Coast, Columbia, Biotechnology Vendor Fair, NY, New York City, Columbia University Medical Center, new Building, NYColumbia University, 2016, Medical equipment
Neuroscience and genetics are two important topics life scientists are consistently studying. Researchers from UC Davis found a promising treatment for Huntington's Disease, while UC San Francisco was awarded $185 million to build a new neuroscience research institute. Recently on the East Coast, a team of researchers from the Columbia University Medical Center discovered a new neurodevelopmental syndrome as well as the genetic makeup of the mutations that cause the syndrome. (Image courtesy of Allen Ajifo via Wikimedia Commons)
The human microbiome is a complex system of bacteria that live and interact in different tissues and organs throughout the body. This complex system is a growing area of focus for life science researchers looking to learn more about these interactions and functions. In order to help its researchers in this rapidly expanding field, Columbia University in New York has established both a working group and a new core facility to help increase research potential of the microbiome.Read More
Achromatopsia - a genetic visual disorder that effects about 1 out of every 33,000 Americans - leads to severe vision problems, generally beginning at a young age. People with this disorder are extremely sensitive to light, have trouble seeing during the day (when it is bright out) and cannot see any color.Read More
- $441 million in annual NIH funding
- $117 million in funding for the creation of two new medical buildings
- A potential of more than $125,000 from sales leads
- "Fantastic experience. Great people, great connections, great food, great show!!"
READ MORE BELOW:
Situated in Upper Manhattan, in the busy, bustling city of New York, Columbia University attracts a wide variety of highly intelligent students and researchers to its world-class facilities. Within the four main graduate schools in the Columbia Medical Center (College of Physicians and Surgeons, College of Dental Medicine, Mailman School of Public Health, School of Nursing), hundreds of researchers work in the different research facilities to find new knowledge and develop therapies to improve public health in New York and around the world.Read More
Glioblastoma is the most aggressive form of brain cancer, and like many other cancers, its causes are still unknown. Since it is generally very malignant, researchers know that glioblastoma cells frequently reproduce to keep the tumor alive and help it grow, and the location of glioblastoma in the brain provides the cells with ample blood supply. Through their study of glioblastomas, researchers at Columbia University Medical Center recently discovered that the gene KLHL9 is a leading factor in the cause of glioblastomas.Read More
Columbia University’s medical school is undergoing a groundbreaking transformation in the most literal sense of the word: Construction crews have broken ground on one of two new medical buildings in the works at the powerhouse university’s campus. The new buildings will include teaching space as well as state-of-the-art science research labs.